To create bio-analytical methods for fixed dose combinations that involve multiple analytes with diverse physico-chemical properties and entail challenging detection limits and large linear dynamic ranges. DCs) in terms of amino acid sequence, drug-to-antibody ratio (DAR) and post-translational modifications.
Sun Pharma is the largest pharmaceutical company in India with around 2,000 research scientists working in multiple R&D centers equipped with cutting-edge technologies for developing generics, APIs, NDDS & NCEs.
Sun Pharma's business is broadly categorized into four segments: Active Pharmaceutical Ingredients (API), International Branded Generics, Indian Branded Generics and US Generics. Sun Pharma works towards generic product development, manufacturing, clinical and preclinical studies leading to regulatory filing globally.